A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration

This publication has 69 references indexed in Scilit:

• RETRACTED: γ-Cleavage-Independent Functions of Presenilin, Nicastrin, and Aph-1 Regulate Cell-Junction Organization and Prevent Tau Toxicity In Vivo
  Neuron, 2006
• Proteolysis of Non-phosphorylated and Phosphorylated Tau by Thrombin
  Published by Elsevier ,2005
• Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals
  Current Drug Targets, 2004
• Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons
  Cell Death & Differentiation, 2003
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
  Bioinformatics, 2003
• Rapid Up-Regulation of Peptide Elongation Factor EF-1α Protein Levels Is an Immediate Early Event during Oxidative Stress-Induced Apoptosis
  Experimental Cell Research, 2000
• Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutations
  Published by Wiley ,1999
• The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology
  Journal of Biological Chemistry, 1996
• Puromycin-sensitive Aminopeptidase
  Published by Elsevier ,1995
• Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease
  Brain Research, 1991